Agenda - Day 3

There are no agenda items with this track

10:00 am

10:00 am

Networking

Networking

Enter Networking Lounge, Connect with Your Industry Colleagues

  • Get a good start on the day and make connections with industry leadership
  • Join “drop-in” roundtables on most topical issues
  • Schedule 1-2-1 video meetings with peers
  • Gather essential content at virtual exhibit booths

11:00 am

11:00 am

Setting Today’s Plan from your Host

Gather your learning take-aways and key highlights of this event to map the current situation and help in achieving success from today’s event.

11:05 am

11:05 am

Explore New Approaches to Developing and Gaining Market Access for Drugs to Treat Rare Diseases

Developing, delivering and funding treatment for patients with rare diseases has become the single biggest challenge for payers, patients and manufacturers.  With a growing consensus that a new drug development model is needed, the question becomes what form should it take?  Gain valuable insights to inform your market access strategy by:

  • Learning what types of partnerships and funding will be key to the successful development of drugs for rare diseases going forward
  • Hearing what impact the increased government funding announced in last fall’s federal budget is having on the pipeline of treatments
  • Understanding what new routes to market and commercialization for these medications may be forged to get them to patients safely and expeditiously

Prepare your organization for a new market access model for treatments for rare diseases.

11:30 am

11:30 am

Industry Expert

Position Your Company to Succeed in the Next Decade with Market Access Metrics and Trends for 2020 and Beyond

The pharmaceutical industry has changed significantly over the past decade, and in many ways change will accelerate affecting most segments of the entire process from drug development to market access.  Prepare your company to adapt to changing market access realities with data-driven insights.  Develop an action plan to evaluate the strategic implications of ongoing change to help you:

  • Understand the factors likely to impact the timeline for your products’ development and prepare early for their seamless launch
  • Analyse how market trends are shaping up for all types of therapies to determine where your next opportunities lie
  • Assess how the increasing digitization of healthcare delivery will impact your relationships with patients and health professionals

Bolster your market access strategy for the next decade with a data-driven approach.

11:50 am

11:50 am

Networking

Networking

Build Relationships, Network and Experience Unparalleled Peer-to-Peer Learning

Expand your network and engage in-depth learning with your peers. Take advantage of any format to further build your knowledge and networking base:

  • “Drop-in” virtual Roundtable chats with up to 15 fellow delegates
  • Cozy 3-4 person discussion
  • Engage in 1:1 video conversation with peers or vendors
  • Vendor solution roundtables

12:20 pm

12:20 pm

What’s Next for Patient Support Programs?

Patient support programs to allow patients access to specialty medications have now become a mainstay in the marketplace over the past couple of decades.  However, there are shifting market dynamics that will likely require your company to develop a new approach to these critical programs.  Gain insight that will allow your company to take incisive steps in forward planning by:

  • Understanding what tensions are now surfacing between support services required and financial sustainability
  • Determining to what extent the entry of biosimilar PSPs increase competition
  • Hearing what vision may be emerging in how PSPs could be re-designed

Gain an edge in patient retention with an improved PSP

12:50 pm

12:50 pm

Panel Discussion

The Impact and Lessons Learned from Covid-19

The Covid-19 pandemic has presented significant challenges across the pharmaceutical industry both from an operations standpoint and in the race to find a vaccine.  Gain valuable insights to help Improve your company’s preparedness to tackle the next infectious incident with lessons learned from Covid-19 and before it, SARS.  Take away actionable insights on:

  • How clinical trials were affected, the financial impact expected and how this can be avoided
  • Managing inventory and patients when the global supply chain is disrupted
  • What steps companies can take to prepare for the next major adverse public health event

Improve your company’s preparedness for the next major adverse public health event

1:20 pm

1:20 pm

Panel Discussion

Improve Your Assessment of the Medical Cannabis Market with the Latest Pharmacoeconomics and Health Canada Policy Developments for Pharmacies

The use of medical cannabis has continued to increase in tandem with greater knowledge concerning its effectiveness in treating various disorders.  Decisions regarding whether your organization should include it in your pipeline or formulary need to be backed by an evidence-based approach.  Discover the latest developments in the use of medical cannabis to assist you to:

  • Better understand the opportunities this market represents and evaluate whether the benefits of entering it outweigh the risks of staying out
  • Assess the growing body of evidence that supports the use of medical cannabis especially among older patients
  • Gain insight into how Health Canada is moving forward with policies for cannabis products in pharmacies

Benefit your organization with an evidence-based approach to decisions on medical cannabis

1:50 pm

1:50 pm

Key Take-Aways and Summary from your Host

Hear the key solutions and take-aways from today’s sessions. Source a summary of actions points for you to implement.

2:00 pm

2:00 pm

Conference Day 3 Adjourns

Get the latest news

*Privacy Policy